Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 250

1.

Proton pump inhibition--the ultimate control of acid secretion?

Zdon MJ, Ballantyne GH, Schafer DE, Tyshkov M, Cambria RP, Modlin IM.

J Surg Res. 1986 Apr;40(4):353-61.

PMID:
2422442
2.

The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.

Wallmark B, Lorentzon P, Larsson H.

Scand J Gastroenterol Suppl. 1985;108:37-51.

PMID:
2988109
3.

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.

Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjöstrand SE, Wallmark B.

Nature. 1981 Mar 12;290(5802):159-61.

PMID:
6259537
4.

Mechanisms of gastric proton pump inhibition by calcium channel antagonists.

Nandi J, King RL, Kaplan DS, Levine RA.

J Pharmacol Exp Ther. 1990 Mar;252(3):1102-7.

PMID:
2156990
5.

Inhibition of acid formation by epidermal growth factor in the isolated rabbit gastric glands.

Dembiński A, Drozdowicz D, Gregory H, Konturek SJ, Warzecha Z.

J Physiol. 1986 Sep;378:347-57.

6.

Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.

Kwon D, Chae JB, Park CW, Kim YS, Lee SM, Kim EJ, Huh IH, Kim DY, Cho KD.

Arzneimittelforschung. 2001;51(3):204-13.

PMID:
11304936
8.

Comparison of five antisecretory agents acting via gastric H+/K+-ATPase.

Bastaki SM, Chandranath I, Garner A.

J Physiol Paris. 2000 Jan-Feb;94(1):19-23.

PMID:
10761684
9.

Syntaxin 3 is required for cAMP-induced acid secretion: streptolysin O-permeabilized gastric gland model.

Ammar DA, Zhou R, Forte JG, Yao X.

Am J Physiol Gastrointest Liver Physiol. 2002 Jan;282(1):G23-33.

10.

Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.

Elander B, Fellenius E, Leth R, Olbe L, Wallmark B.

Scand J Gastroenterol. 1986 Apr;21(3):268-72.

PMID:
3012768
12.

Decreased parietal cell secretory capacity following vagotomy and pyloroplasty.

Zdon MJ, Lewis JJ, Adrian TE, Modlin IM.

J Surg Res. 1989 May;46(5):490-5.

PMID:
2716307
13.

Pharmacology of gastric acid inhibition.

Shamburek RD, Schubert ML.

Baillieres Clin Gastroenterol. 1993 Mar;7(1):23-54. Review.

PMID:
8097411
14.

Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.

Shamburek RD, Schubert ML.

Gastroenterol Clin North Am. 1992 Sep;21(3):527-50. Review.

PMID:
1355465
15.

Characteristics of the spontaneous gastric endocrine tumor of mastomys.

Modlin IM, Zucker KA, Zdon MJ, Sussman J, Adrian TE.

J Surg Res. 1988 Mar;44(3):205-15.

PMID:
3343820
16.

Activation of parietal cell by mercaptomethylimidazole: a novel inducer of gastric acid secretion.

Bandyopadhyay U, Chatterjee R, Chakraborty TK, Ganguly CK, Bhattacharyya DK, Banerjee RK.

Biochem Pharmacol. 1997 Jul 15;54(2):241-8.

PMID:
9271328
17.

Prostaglandin inhibition of acid is cAMP dependent.

Zucker KA, Zdon MJ, Adrian TE, Ballantyne GH, Modlin IM.

J Surg Res. 1987 May;42(5):513-20.

PMID:
3035281
18.

Gastric acid secretion is augmented by the replacement of extracellular Na+ with K+ or other ions.

Akagi K, Hasebe K, Watanabe K, Nagao T, Urushidani T.

Jpn J Pharmacol. 1998 Oct;78(2):147-59.

19.

Cyclo-oxygenase-1 inhibition increases acid secretion by modulating H+,K+-ATPase expression and activation in rabbit parietal cells.

Nandi J, Das PK, Zinkievich JM, Baltodano JD, Levine RA.

Clin Exp Pharmacol Physiol. 2009 Feb;36(2):127-34. doi: 10.1111/j.1440-1681.2008.05032.x. Epub 2008 Aug 26.

PMID:
18759857
20.

Supplemental Content

Support Center